Coherus BioSciences (CHRS) Reports Q1 Loss Per Share of $1.22
Tweet
Share
E-mailGet Alerts CHRS Hot Sheet
Price: $2.18 --0%
Financial Fact:
Diluted net income/(loss) per share: 0.15
Today's EPS Names:
SEIC, OSBC, USAP, More
Financial Fact:
Diluted net income/(loss) per share: 0.15
Today's EPS Names:
SEIC, OSBC, USAP, More
Join SI Premium – FREE
Coherus BioSciences (NASDAQ: CHRS) reported Q1 EPS of ($1.22), versus ($6.03) reported last year.
For earnings history and earnings-related data on Coherus BioSciences (CHRS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Visa (V) stock rises as Q2 earnings, revenue come ahead of estimates
- Trustmark Corp (TRMK) Tops Q1 EPS by 7c
- Orange shares down despite reporting in-line core operating profit in Q1
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
